Anixa Biosciences

Our CEO, Dr. Amit Kumar, joined Smart Money Circle with Adam Sarhan to discuss Anixa’s innovative approach to cancer treatment and prevention. Watch the full interview: youtu.be/96uSUv6CzuY Thank you @adamsarhan for the conversation. #Biotech #CancerResearch #Immunotherapy #Oncology #Innovation #Healthcare

Check out our latest Healthcare Happenings as we welcome back Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences, Inc. (NASDAQ: $ANIX) who explains why 2026 is shaping up to be a pivotal year for the company. Hosted by WTR's Tim Gerdeman & Robert Sassoon. Check out the full episode below! Podcast Platforms: pod.link/1795488592 Website: watertowerresearch.com/media-detail/3… #HealthcareInvesting #Biotech #BiotechStocks $ANIX #CancerResearch #Immunotherapy #BiotechInnovation #HealthcareStocks #LifeSciences #ClinicalDevelopment #PrecisionMedicine #SmallCapBiotech #InvestorInsights #HealthcareInnovation @AnixaBio

🎙️ New Podcast: Water Tower Research In this episode of WTR Healthcare Happenings, Anixa Biosciences CEO Dr. Amit Kumar discusses why 2026 may be a pivotal year for Anixa. 🎧 Listen here: watertowerresearch.com/media-detail/3… The discussion also explores Anixa’s clinical-stage programs, including its ovarian cancer immunotherapy and breast cancer vaccine initiatives. #AnixaBiosciences #Biotech #CancerResearch #Immunotherapy #ANIX

🎙️ New podcast: Can we prevent breast cancer? In this episode, Anixa Biosciences CEO Dr. Amit Kumar discusses the investigational breast cancer vaccine being developed in collaboration with Cleveland Clinic and the clinical research exploring how immunotherapy may help prevent or treat the disease. ▶️ Watch on YouTube: youtube.com/watch?v=_Ijeme… 🎧 Listen on: Spotify: open.spotify.com/episode/0JxKKR… Apple Podcasts: podcasts.apple.com/us/podcast/can… 📺 Media coverage: foxcarolina.com/video/2026/03/… #AnixaBiosciences #Biotech #Immunotherapy #CancerResearch #BreastCancer

An investigational breast cancer vaccine being developed by Anixa Biosciences in collaboration with Cleveland Clinic is featured in new NBC Chicago coverage. The program is exploring an immunotherapy approach designed to train the immune system to target a protein associated with breast cancer. 🎥 Watch the story: nbcchicago.com/video/local/va… #AnixaBiosciences #Biotech #CancerResearch #Immunotherapy #ClinicalTrials

Advancing innovation in the fight against breast cancer 💙 A patient in a clinical trial of our investigational breast cancer vaccine shares her experience—highlighting the potential of this novel immunotherapy approach. Read more via @foxcarolinanews: foxcarolina.com/2026/02/26/bre… #BreastCancer #CancerVaccine #Immunotherapy #ClinicalTrials #Biotech #Oncology

Encouraging observations from our ovarian cancer CAR-T clinical trial. Multiple patients are living significantly longer than expected and no dose-limiting toxicities have been observed to date. These results support expanded dosing and continued clinical evaluation. 🔗Read the full press release: ir.anixa.com/press-releases… $ANIX #AnixaBiosciences #CARTTherapy #CancerResearch #ClinicalTrials

Looking forward to our fireside chat with Robert Sassoon of @WTR_Research at 11:00am ET on Tuesday, February 10. Register to attend here: event.webcasts.com/starthere.jsp?…

We're listening to iHeart ♫ @iHeartRadio iheart.com/podcast/176-sa…

We’re happy to share additional coverage highlighting that the breast cancer vaccine trial, developed with partners including Cleveland Clinic, is advancing into Phase 2 testing after an immune response in over 70% of participants and a favorable safety profile. Phase 2 will include more participants and control comparisons to further evaluate safety and efficacy. 🔗Full article: ideastream.org/health/2025-12… $ANIX #AnixaBiosciences #BreastCancerVaccine #Immunotherapy #ClinicalTrials #Biotech

We’re encouraged by worldwide coverage, including by @timesofindia, of the Phase 1 clinical trial results showing our breast cancer vaccine was safe, well-tolerated, and triggered a strong immune response, a hopeful step in the fight against this aggressive disease. 🔗Read the full article: timesofindia.indiatimes.com/life-style/hea… $ANIX #AnixaBiosciences #BreastCancer #CancerResearch #Immunotherapy #Biotech

We’re pleased by news coverage from @NBCNews on the promising Phase 1 clinical trial results for our breast cancer vaccine that generated strong immune responses in Phase 1 — a hopeful step toward prevention and less recurrence for this aggressive cancer subtype. 🔗Read more: nbcnews.com/health/cancer/… $ANIX #AnixaBiosciences #BreastCancer #Immunotherapy #CancerResearch #Biotech

📢 We’re encouraged by the promising Phase 1 results from our breast cancer vaccine trial developed in collaboration with Cleveland Clinic — showing the vaccine is safe and triggered an immune response in over 70% of participants. 🔗 Read more: wkyc.com/article/news/h… $ANIX #AnixaBiosciences #BreastCancerVaccine #Immunotherapy #ClinicalTrials #Biotech

📣 We’re excited to share positive Phase 1 data from our investigational breast cancer vaccine! Final results presented at the 2025 San Antonio Breast Cancer Symposium showed the vaccine met all major primary endpoints, was safe and well tolerated, and elicited protocol-defined immune responses in 74% of participants, supporting advancement into Phase 2 development. 🔗 Full press release: ir.anixa.com/press-releases… $ANIX #AnixaBiosciences #BreastCancerVaccine #BreastCancer #Immunotherapy #ClinicalTrials #Biotech

Anixa Biosciences $ANIX CEO, Dr. Amit Kumar, will be participating in the Water Tower Research Fireside Chat Series on December 15, to talk about the results of the Phase 1 clinical trial of our breast cancer vaccine. x.com/WTR_Research/s… #ANIX #AnixaBiosciences #BreastCancer #Immunotherapy

🚀 We’re honored to be featured by Meditech Wire for our work to shift from treatment to prevention in cancer care. 🔬 Our breast-cancer vaccine program points to a future where we can stop cancer before it starts. 🔗 Full article: meditechwire.com/anixa-bioscien… $ANIX #CancerPrevention #Immunotherapy #biotech

Promising breast cancer vaccine could be available by 2030, researchers say wptv.com/news/health/pr…

🚀 Anixa Biosciences will present at the Spartan Capital Securities Investor Conference on Nov 3 in NYC. President & CFO, Mike Catelani will deliver the presentation and host 1-on-1 meetings. 🔗 Full press release: ir.anixa.com/press-releases… $ANIX #BreastCancer #OvarianCancer #Immunotherapy

🔁 We appreciate the coverage from @WTR_Research highlighting our continued progress in advancing innovative immunotherapy programs — including our breast and ovarian cancer vaccine platforms. Together with our research partners, we remain committed to driving transformative solutions in cancer prevention and treatment. #Immunotherapy #CancerResearch #BreastCancer #OvarianCancer

Big news! 🚀 A Chinese patent (ZL2020800215666) has been issued for our breast cancer vaccine technology, expanding our global IP portfolio. Read more ➡️ ir.anixa.com/press-releases… #BreastCancer #CancerVaccine #Immunotherapy